Lipocine, Inc. (LPCN)
2.315
+0.06
(+2.89%)
USD |
NASDAQ |
Sep 10, 15:28
Lipocine Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0008 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0349 |
| December 31, 2021 | 0.0507 |
| September 30, 2021 | 0.0956 |
| June 30, 2021 | 0.1107 |
| March 31, 2021 | 0.1127 |
| December 31, 2020 | 0.3644 |
| September 30, 2020 | 0.4382 |
| June 30, 2020 | 0.4841 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9698 |
| December 31, 2019 | 1.137 |
| September 30, 2019 | 1.057 |
| June 30, 2019 | 0.885 |
| March 31, 2019 | 0.7564 |
| December 31, 2018 | 1.088 |
| September 30, 2018 | 0.8668 |
| June 30, 2018 | 0.7299 |
| March 31, 2018 | 0.6037 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 23.84M |
| Total Liabilities (Quarterly) | 2.068M |
| Shareholders Equity (Quarterly) | 21.77M |
| Current Ratio | 11.48 |